Hepatology : Impact Factor & More
eISSN: 1527-3350pISSN: 0270-9139
Share this on:
Key Metrics
CiteScore 
25.8
H-Index
387
Impact Factor
10 - 15
Scite Index
0.89 5-Year SI
SJR
Q1Hepatology
SNIP
3.92
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Hepatology
Hepatology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1981 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Hepatology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Hepatology
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
- 7 Aug 2026
- Hepatology (Baltimore, Md.)
With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.
- 6 Aug 2026
- Hepatology (Baltimore, Md.)
Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).
- 4 Aug 2026
- Hepatology (Baltimore, Md.)
Hepatocyte MLKL drives obesity-driven hepatocellular carcinoma progression via mitochondrial dysfunction independent of necroptosis in MASLD.
- 4 Aug 2026
- Hepatology (Baltimore, Md.)
Weight reduction-dependent/-independent effects of survodutide on liver endpoints: Mediation analysis of a phase 2 trial in MASH.
- 3 Aug 2026
- Hepatology (Baltimore, Md.)
Erratum: AlphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma.
- 1 Aug 2026
- Hepatology (Baltimore, Md.)
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
- 7 Aug 2026
- Hepatology (Baltimore, Md.)
With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.
- 6 Aug 2026
- Hepatology (Baltimore, Md.)
Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).
- 4 Aug 2026
- Hepatology (Baltimore, Md.)
Hepatocyte MLKL drives obesity-driven hepatocellular carcinoma progression via mitochondrial dysfunction independent of necroptosis in MASLD.
- 4 Aug 2026
- Hepatology (Baltimore, Md.)
Weight reduction-dependent/-independent effects of survodutide on liver endpoints: Mediation analysis of a phase 2 trial in MASH.
- 3 Aug 2026
- Hepatology (Baltimore, Md.)
Erratum: AlphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma.
- 1 Aug 2026
- Hepatology (Baltimore, Md.)
FAQs on Hepatology
How long has Hepatology been actively publishing? 
What is the publishing frequency of Hepatology?
How many articles did Hepatology publish last year?
What is the eISSN & pISSN for Hepatology?
What is Citescore for Hepatology?
What is the H Index for Hepatology ?
What is SNIP score for Hepatology?
What is the SJR for Hepatology?
Who is the publisher of Hepatology?
